blindness from semaglutide Does Use Lead to Blindness? Nordisk slams study linking rare

Scalp health optimization Scalp inflammation, seborrheic dermatitis, and folliculitis can all worsen hair loss during GLP-1 therapy

Where the worry comes from: the FDA boxed warning Every GLP-1 receptor agonist approved for weight loss or type 2 diabetes in the United States carries a boxed warning, the strongest type of caution the U.S

These changes will go into effect on January 5, 2026

These symptoms are not always due to ischaemic optic neuropathy and often have other explanations, but they should never be ignored or left in the hope they settle. Symptoms to Watch For Patients taking a GLP-1 medication should be alert to any sudden or unexplained change in vision